V8 Peptides — Engineered Performance
Research Library
MOTS-c in High-Fat-Diet Mice: Model Design Guide
MOTS-cGuide

MOTS-c in High-Fat-Diet Mice: Model Design Guide

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What do published mouse studies report about MOTS-c and high-fat diet? The 2015 discovery paper reported that MOTS-c exposure in mice prevented age-dependent and high-fat-diet-induced insulin resistance and diet-induced obesity, and that the peptide's target organ appears to be skeletal muscle. A 2019 paper reported that exposure in ovariectomized mice prevented obesity and insulin resistance and sustained brown fat activity. This guide takes the design view: what a diet-induced obesity experiment has to control for, which endpoints belong in it and how to report it. It covers published mouse work only. MOTS-c is supplied for laboratory research use only.

The model in one paragraph

A diet-induced obesity model feeds mice a high-fat diet for a set period and compares them with mice fed a control diet. Body weight, fat mass, glucose handling and energy balance are then followed. It is widely used because it produces weight gain and insulin resistance without a genetic lesion, and it is the model in which the first MOTS-c paper reported its obesity result.[1] The weakness of any diet model is that outcomes depend heavily on diet composition, strain, sex, age at start and housing, so each of these must be stated. A companion article covers how insulin sensitivity itself is measured; the compound profile is in the MOTS-c research overview.

What the two key studies report

FeatureLee 2015[1]Lu 2019[2]
Obesity modelHigh-fat diet and age-dependent insulin resistanceOvariectomy-induced obesity
Exposure effect reportedPrevented diet-induced obesity and insulin resistancePrevented body-weight gain and insulin resistance
Adipose findingsNot detailed in the abstractReduced fat mass; increased brown fat activation; less inflammatory invasion of white fat; lower serum and liver fatty acid
Target organ or tissueSkeletal muscleAdipose tissue
MechanismFolate cycle and purine biosynthesis inhibition, AMPK activationAMPK pathway activation; blocker attenuated effect on adipocyte lipid metabolism

The comparison shows why more than one obesity model is informative: a diet model engages nutrient oversupply, while the ovariectomy model engages hormonal loss, and a mechanism that holds in both is less likely to be specific to one.

Design decisions that determine interpretability

DecisionWhy it mattersReporting standard
Control diet matched to the high-fat dietDifferent control diets differ in more than fatState both diet compositions
Start age and durationAge interacts with the diet effect, and the 2015 paper itself involved age-dependent resistance[1]State age at start and weeks on diet
Strain and sexSusceptibility to diet obesity variesState strain and sex; analyze sexes separately
Prevention versus reversal designExposure started with the diet answers a different question than exposure after obesity is establishedState when exposure began relative to diet
Randomization and blindingBody weight differences at baseline bias resultsRandomize on baseline weight
HousingGroup housing hides individual intakeState caging and handling
Food intakeWeight change can come from intake or expenditureMeasure intake, ideally with a pair-fed arm

Prevention and reversal are different experiments. A prevention design asks whether an intervention changes the trajectory of a diet challenge; a reversal design asks whether it can lower established obesity. Abstracts often say "prevented" or "reduced" without making the design obvious, which is why the full methods matter.

Endpoints to include

  • Body weight over time, with fat and lean mass by a body-composition method where available.
  • Food intake, to separate appetite from metabolic effects.
  • Glucose handling and insulin sensitivity, with the test type stated.[3]
  • Energy expenditure, if indirect calorimetry is available.
  • Adipose histology and inflammatory markers, as in the ovariectomy study, which reported reduced inflammatory invasion in white adipose tissue.[2]
  • Tissue AMPK activation, with total and phosphorylated forms; see the companion article on AMPK assays for the tool-compound caveats.
  • Skeletal muscle readouts, since muscle was reported as the primary target organ.[1]

Standardized procedures for mouse glucose-homeostasis tests are available from a consortium and recommend how to describe methods and present data.[3]

Worked layout of a prevention-design study

GroupDietExposurePurpose
1Control dietVehicleReference for normal weight gain
2Control dietMOTS-cTests effects independent of diet challenge
3High-fat dietVehicleReference for the diet effect
4High-fat dietMOTS-cTests prevention of the diet effect
5High-fat dietVehicle, pair-fed to group 4 intakeSeparates intake effects from metabolic ones

A five-group layout keeps the diet effect, the peptide effect and the intake effect separable. Exposure begins with the diet in this layout, which answers the prevention question; a reversal study would start exposure after a pre-feeding period and would add a baseline-matched randomization step at that point. Sample size should be set before the study from a pilot estimate of the variability in the primary endpoint, and the primary endpoint should be named in advance, so that secondary endpoints are not presented as confirmatory.

Confounders specific to peptide studies

Peptide exposure adds its own variables. The vehicle, route and schedule must match between arms. Handling stress from frequent administration can reduce food intake and weight, so the vehicle arm must be handled identically. Peptide stability matters: the two methionines can oxidize, so solutions should be prepared fresh or stored in single-use portions at the storage tier on the product page. The material should be traceable to a lot, with a COA where one is published; compare with the COA library where a lot is published, and read MOTS-c purity testing. Reconstitution reasoning is in MOTS-c reconstitution and storage.

Concentration arithmetic, formula only

Published amounts in animal work are expressed per kilogram body weight and are not converted or recommended here. For any stock solution, concentration (mmol/mL) = mass (mg) ÷ molecular weight (g/mol) ÷ volume (mL), with about 2,175 g/mol for MOTS-c. The calculator performs the arithmetic. Record the diluent, the stock concentration, the time since reconstitution and the storage tier for every batch used.

Reading adipose and muscle endpoints

Body weight can mask opposite changes in fat and lean mass, so a weight difference should be followed by body composition. In adipose tissue, histology reports adipocyte size and immune-cell infiltration, as in the ovariectomy study that described reduced inflammatory invasion in white fat.[2] In muscle, the relevant readouts are insulin-signaling and AMPK phosphorylation and mitochondrial markers, because muscle was reported as the primary target organ in the first paper.[1] Collect tissues at a fixed time relative to the last administration and feeding, since both change signaling readouts within hours.

Limits of the evidence

The sources reviewed here are two mouse papers from different groups and a consortium guideline. The abstracts do not give the diet composition, strain, exposure schedule or effect sizes, so this guide cannot say how large the reported effects were or compare them. Readers should obtain the full papers before designing a replication, and should regard the AMPK link as a hypothesis supported by pharmacological blockers rather than a closed question. Neither paper is evidence about any use outside the laboratory.

Reporting and research-use statement

A complete methods paragraph names the diet products, strain, sex, ages, diet duration, exposure start, vehicle, schedule, randomization method, blinding, exclusions and the number of animals per group. These items are needed whatever the result. All material discussed here is supplied for laboratory research use only; not for human or animal consumption, and not a drug, food or cosmetic.

Related reading

Frequently asked questions

What diet model do the MOTS-c papers use?

The 2015 paper reported effects on high-fat-diet-induced obesity and insulin resistance in mice;[1] the 2019 paper used ovariectomy-induced obesity.[2]

Prevention or reversal?

The abstracts use "prevented", which suggests a prevention framing, but the full methods should be read for when exposure began.

Why measure food intake?

Weight change can come from lower intake or higher expenditure; measuring intake separates them.

What did the ovariectomy study add?

Reduced fat mass, brown fat activation, less white-fat inflammatory invasion and AMPK involvement.[2]

Why report strain and sex?

Susceptibility to diet-induced obesity varies, so results may not transfer.

How should glucose handling be tested?

With a described test (glucose tolerance, insulin tolerance or clamp) following consortium guidance.[3]

Why match the control diet?

Control diets differ in more than fat content, so a mismatch confounds the comparison.

Why handle the vehicle arm identically?

Handling stress changes intake and weight and would otherwise be attributed to the peptide.

How is a stock calculated?

Mass in mg divided by about 2,175 g/mol, divided by volume in mL; use the calculator.

Is MOTS-c intended for people or animals?

No. It is supplied for laboratory research use only; not for human or animal consumption.

Related reading: MOTS-c Origin: A Peptide Encoded in Mitochondrial DNA, MOTS-c in Aged Mice: Published Findings on Physical Decline, MOTS-c and AMPK: Assays, Tool Compounds and Controls.

References

  1. Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015. doi:10.1016/j.cmet.2015.02.009 PMID: 25738459
  2. Lu H, et al. MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. J Mol Med. 2019. doi:10.1007/s00109-018-01738-w PMID: 30725119
  3. Ayala JE, et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech. 2010. doi:10.1242/dmm.006239 PMID: 20713647

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.